Clinical Trials
36
Active:0
Completed:20
Trial Phases
4 Phases
Phase 2:1
Phase 3:12
Phase 4:12
+1 more phases
Drug Approvals
263
PHILIPPINES:179
FDA:72
CANADA:6
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
Distribution across different clinical trial phases (35 trials with phase data)• Click on a phase to view related trials
Phase 3
12 (34.3%)Phase 4
12 (34.3%)Not Applicable
9 (25.7%)Phase 2
1 (2.9%)phase_2_3
1 (2.9%)No trials found
News
Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition
The Indian Patent Office revoked Novartis' patent for Vymada (Entresto), a heart failure drug generating $7.8 billion in global sales, citing lack of novelty and inventive step.
Esperion Secures Patent Protection for NEXLETOL Until 2040 Through Settlement with Micro Labs
Esperion Therapeutics has reached a settlement agreement with Micro Labs that prevents the generic manufacturer from marketing a version of NEXLETOL (bempedoic acid) before April 19, 2040.
Allchem Lifescience Files for IPO to Raise ₹190 Crore, Expands API Manufacturing Capabilities
Gujarat-based Allchem Lifescience has filed preliminary IPO papers with SEBI, seeking to raise ₹190 crore through fresh equity shares and an offer for sale of 71.55 lakh shares by promoters.